|
Medtronic received a report that onyx was being used for embolization of an arteriovenous fistula (av fistula).An apollo 3 cm tip microcatheter was used to deliver the onyx.The apollo was advanced through the middle meningeal artery (mma) feeder, and the onyx was flowing as intended with minimal reflux.At one point, the onyx was still flowing, but it was no longer visible on the roadmap image, which had been magnified on the fistula.The physician did not feel any pressure during injection and stopped when the flow could no longer be seen.After zooming out, the physician observed that the onyx was also flowing proximally due to a hole in the apollo microcatheter.This caused onyx to flow into the petrosal branch and resulted in facial paralysis in the patient.The reported issue was a catheter leak, located distally, which was observed during use despite the catheter having been inspected and tested prior t o use.It was noted the patient's vessel tortuosity was normal.Access vessel was the mma.The reported device and any accessory devices were prepared and the catheter was flushed as indicated in the instructions for use (ifu).Ancillary devices include a guide catheter, apollo microcatheter, balt 12/14 hybrid guidewire, onyx 18 and 34 liquid embolic.
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|